Pfam Domains GO Terms
| A2M N |
| A2M N 2 |
| Thiol-ester cl |
| NTR |
| ANATO |
| A2M recep |
| A2M comp |
| A2M |
| C5L2 anaphylatoxin chemotactic receptor binding |
| complement-dependent cytotoxicity |
| positive regulation of activation of membrane attack complex |
| vertebrate eye-specific patterning |
| positive regulation of type II hypersensitivity |
| regulation of activation of membrane attack complex |
| positive regulation of type IIa hypersensitivity |
| regulation of type II hypersensitivity |
| regulation of type IIa hypersensitivity |
| complement-mediated synapse pruning |
| positive regulation of complement activation |
| positive regulation of hypersensitivity |
| positive regulation of apoptotic cell clearance |
| positive regulation of acute inflammatory response to antigenic stimulus |
| regulation of hypersensitivity |
| regulation of apoptotic cell clearance |
| synapse pruning |
| neuron remodeling |
| positive regulation of inflammatory response to antigenic stimulus |
| complement activation, alternative pathway |
| regulation of acute inflammatory response to antigenic stimulus |
| positive regulation of membrane invagination |
| positive regulation of phagocytosis, engulfment |
| regulation of phagocytosis, engulfment |
| regulation of membrane invagination |
| regulation of triglyceride biosynthetic process |
| positive regulation of humoral immune response |
| positive regulation of lipid storage |
| amyloid-beta clearance |
| regulation of inflammatory response to antigenic stimulus |
| positive regulation of G protein-coupled receptor signaling pathway |
| positive regulation of vascular endothelial growth factor production |
| positive regulation of acute inflammatory response |
| positive regulation of myeloid leukocyte mediated immunity |
| regulation of vascular endothelial growth factor production |
| endopeptidase inhibitor activity |
| regulation of triglyceride metabolic process |
| positive regulation of B cell mediated immunity |
| positive regulation of immunoglobulin mediated immune response |
| neuron maturation |
| positive regulation of glucose transmembrane transport |
| regulation of acute inflammatory response |
| regulation of lipid storage |
| regulation of B cell mediated immunity |
| regulation of immunoglobulin mediated immune response |
| positive regulation of receptor-mediated endocytosis |
| regulation of myeloid leukocyte mediated immunity |
| positive regulation of phagocytosis |
| regulation of glucose transmembrane transport |
| positive regulation of lipid localization |
| cell killing |
| azurophil granule lumen |
| regulation of phagocytosis |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| positive regulation of endocytosis |
| regulation of receptor-mediated endocytosis |
| positive regulation of lymphocyte mediated immunity |
| positive regulation of adaptive immune response |
| secretory granule lumen |
| regulation of complement activation |
| positive regulation of leukocyte mediated immunity |
| anatomical structure maturation |
| regulation of humoral immune response |
| regulation of lipid localization |
| positive regulation of inflammatory response |
| blood microparticle |
| regulation of G protein-coupled receptor signaling pathway |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| regulation of lymphocyte mediated immunity |
| cell maturation |
| regulation of adaptive immune response |
| complement activation, classical pathway |
| positive regulation of angiogenesis |
| humoral immune response mediated by circulating immunoglobulin |
| complement activation |
| positive regulation of vasculature development |
| regulation of lipid biosynthetic process |
| positive regulation of transmembrane transport |
| regulation of endocytosis |
| regulation of leukocyte mediated immunity |
| immunoglobulin mediated immune response |
| B cell mediated immunity |
| positive regulation of immune effector process |
| developmental maturation |
| negative regulation of endopeptidase activity |
| negative regulation of peptidase activity |
| lymphocyte mediated immunity |
| synapse organization |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| regulation of angiogenesis |
| endoplasmic reticulum lumen |
| regulation of vasculature development |
| fatty acid metabolic process |
| regionalization |
| signaling receptor binding |
| regulation of inflammatory response |
| humoral immune response |
| negative regulation of proteolysis |
| visual system development |
| post-translational protein modification |
| sensory system development |
| regulation of lipid metabolic process |
| cellular component disassembly |
| regulation of endopeptidase activity |
| cell surface receptor signaling pathway involved in cell-cell signaling |
| pattern specification process |
| regulation of peptidase activity |
| positive regulation of cytokine production |
| negative regulation of hydrolase activity |
| regulation of immune effector process |
| positive regulation of defense response |
| neutrophil degranulation |
| neutrophil activation involved in immune response |
| neutrophil mediated immunity |
| inflammatory response |
| neutrophil activation |
| granulocyte activation |
| leukocyte degranulation |
| myeloid leukocyte mediated immunity |
| myeloid cell activation involved in immune response |
| monocarboxylic acid metabolic process |
| regulation of vesicle-mediated transport |
| regulation of transmembrane transport |
| myeloid leukocyte activation |
| protein-containing complex |
| positive regulation of response to external stimulus |
| adaptive immune response |
| cell surface |
| leukocyte activation involved in immune response |
| cell activation involved in immune response |
| activation of immune response |
| response to bacterium |
| regulation of cytokine production |
| regulated exocytosis |
| regulation of proteolysis |
| regulation of defense response |
| leukocyte mediated immunity |
| innate immune response |
| negative regulation of catalytic activity |
| exocytosis |
| neuron development |
| positive regulation of immune response |
| carboxylic acid metabolic process |
| leukocyte activation |
| defense response to other organism |
| cellular lipid metabolic process |
| central nervous system development |
| positive regulation of transport |
| oxoacid metabolic process |
| secretion by cell |
| neuron differentiation |
| positive regulation of protein phosphorylation |
| organic acid metabolic process |
| negative regulation of cellular protein metabolic process |
| export from cell |
| positive regulation of phosphorylation |
| regulation of anatomical structure morphogenesis |
| cell activation |
| immune effector process |
| regulation of response to external stimulus |
| negative regulation of protein metabolic process |
| cell-cell signaling |
| secretion |
| positive regulation of phosphorus metabolic process |
| positive regulation of phosphate metabolic process |
| negative regulation of molecular function |
| positive regulation of immune system process |
| regulation of immune response |
| positive regulation of cellular component organization |
| lipid metabolic process |
| positive regulation of protein modification process |
| regulation of hydrolase activity |
| response to other organism |
| response to external biotic stimulus |
| G protein-coupled receptor signaling pathway |
| response to biotic stimulus |
| defense response |
| positive regulation of developmental process |
| regulation of protein phosphorylation |
| regulation of response to stress |
| generation of neurons |
| regulation of phosphorylation |
| extracellular space |
| positive regulation of cellular protein metabolic process |
| neurogenesis |
| cell development |
| regulation of immune system process |
| positive regulation of signal transduction |
| positive regulation of protein metabolic process |
| positive regulation of multicellular organismal process |
| small molecule metabolic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of protein modification process |
| regulation of transport |
| immune response |
| extracellular region |
| vesicle-mediated transport |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Pimelic-diphenylamide-106 0.5μM R00 exp27 | 1.8 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution